MICROPORT CRM S.R.L. PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION
|
Back to Search Results |
|
Model Number PLATINIUM SONR CRT-D 1841 |
Device Problems
Over-Sensing (1438); Pacing Intermittently (1443)
|
Patient Problems
No Information (3190); Insufficient Information (4580)
|
Event Date 10/07/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by microport crm that was cleared or approved by fda for marketing in the united states.
|
|
Event Description
|
The subject crt-d was implanted as a replacement device on (b)(6) 2018, and connected to already implanted atrial and ventricular leads.The patient is pacing-dependent.Reportedly, during a follow-up performed on (b)(6) 2021, several episodes recorded in the device memory until (b)(6) 2020 showed ventricular noise oversensing, leading to ventricular pacing inhibition.No inappropriate therapy was delivered as a result of the oversensing.The patient did not report any symptoms.Capture threshold, lead impedance and detection values were within normal range.The physician decided to schedule a re-intervention to replace the right ventricular lead, as a lead issue was suspected.On (b)(6) 2021, the right ventricular lead was abandoned in patient¿s body and replaced.Preliminary analysis revealed that the observed noise could have resulted from electromagnetic interferences (emi) and/or myopotentials.Nevertheless, the beginning of a ventricular lead issue could not be excluded with certainty.
|
|
Manufacturer Narrative
|
Please refer to the attached analysis report.
|
|
Event Description
|
The subject crt-d was implanted as a replacement device on (b)(6) 2018, and connected to already implanted atrial and ventricular leads.The patient is pacing-dependent.Reportedly, during a follow-up performed on (b)(6) 2021, several episodes recorded in the device memory until (b)(6) 2020 showed ventricular noise oversensing, leading to ventricular pacing inhibition.No inappropriate therapy was delivered as a result of the oversensing.The patient did not report any symptoms.Capture threshold, lead impedance and detection values were within normal range.The physician decided to schedule a re-intervention to replace the right ventricular lead, as a lead issue was suspected.On (b)(6) 2021, the right ventricular lead was abandoned in patient's body and replaced.Preliminary analysis revealed that the observed noise could have resulted from electromagnetic interferences (emi) and/or myopotentials.Nevertheless, the beginning of a ventricular lead issue could not be excluded with certainty.
|
|
Search Alerts/Recalls
|
|
|